R&D

News

Oxford's malaria shot set for phase 3 test after 'unpreceden...

Following the success of the coronavirus vaccine developed with AstraZeneca, Oxford University's Jenner Institute has unveiled trial results showing its experimental malaria shot could be a

News

Businessmen trading stocks online. Stock brokers looking at graphs, indexes and numbers on multiple computer screens. Colleagues in discussion in traders office. Business success concept.

Centessa plans $100m IPO to fund R&D and potential acquisiti...

Centessa has announced plans for a $100m US IPO just weeks after the company launched with $250m in private backing and an R&D powerhouse driven by the merger of 10 biotechs.

News

UK Vaccine Taskforce head lifts lid on Novavax deal

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce.&nbs

News

Activist investor Elliott builds stake in GSK after fresh tr...

Activist investor Elliott Management has built a significant stake in GlaxoSmithKline, after a poor run of clinical trial results this year raised questions about management’s strategy to t

News